SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001144204-08-009267
Filing Date
2008-02-14
Accepted
2008-02-14 14:25:44
Documents
1

Document Format Files

Seq Description Document Type Size
1 v103639_sc13g.htm SC 13G 137369
  Complete submission text file 0001144204-08-009267.txt   139240
Mailing Address 4225 EXECUTIVE SQUARE SUITE 460 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 460 LA JOLLA CA 92037 (858) 457-5300
TRANSDEL PHARMACEUTICALS INC (Subject) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-83793 | Film No.: 08613391
SIC: 2834 Pharmaceutical Preparations

Mailing Address TRANSDEL PHARMACEUTICALS, INC. 4225 EXECUTIVE SQUARE, SUITE 460 LA JOLLA CA 92037
Business Address (858) 457-5300
Singh Juliet (Filed by) CIK: 0001421383 (see all company filings)

Type: SC 13G